Skip to content

Semaglutide Support

  1. Home
  2. Why BHB
  3. Semaglutide Support

Semaglutide Support

goBHB® + Semaglutide Support

Reduce Side Effects. Protect Muscle. Sustain Results.

The GLP-1 Revolution—and Its Gaps

GLP-1 receptor agonists like semaglutide (Ozempic®, Wegovy®) have transformed weight management. Millions are now using these therapies to achieve significant fat loss with reduced appetite .

But alongside their benefits come real challenges:

  • Nausea, vomiting, and GI discomfort
  • Fatigue and reduced exercise tolerance
  • Increased heart rate in some individuals
  • Loss of lean muscle mass during rapid weight reduction

For long-term success, patients need metabolic support that not only eases treatment but also helps sustain results after GLP-1 therapy ends.

Why goBHB® Works with GLP-1

goBHB® is a bioidentical ketone that provides direct cellular energy (ATP) to the brain, heart, and muscles. Unlike glucose, it delivers clean fuel with 225% more energy yield and far less oxidative stress .

When paired with semaglutide:

  • Mitigates fatigue and nausea by supplying steady energy during reduced glucose intake.
  • Preserves muscle mass while weight is lost, supporting a healthier body composition .
  • Supports appetite suppression naturally, reinforcing GLP-1’s mechanism.
  • Stabilizes metabolism post-therapy, lowering risk of rebound weight gain.

These statements have not been evaluated by the FDA.

Product Design Concept

A patented BHB + GLP-1 support formula would be designed to work both during and after semaglutide therapy:

During treatment

  • BHB provides alternative energy, reducing fatigue and GI-related discomfort.
  • Supports muscle retention while fat mass decreases.
  • Enhances satiety signaling to strengthen weight loss outcomes.

After treatment

  • Maintains weight loss results with continued appetite control.
  • Supports metabolic flexibility and energy balance.
  • Helps prevent post-treatment regain by fueling both brain and muscle.

Target Audiences

  • Current GLP-1 Users: Managing side effects and aiming for smoother treatment.
  • Potential GLP-1 Users: Considering therapy but concerned about fatigue or muscle loss.
  • Post GLP-1 Users: Seeking to maintain weight and avoid costly re-treatment .

Clinical Rationale

Research demonstrates goBHB’s benefits in weight management:

  • Fat loss and body composition: 10 g/day of goBHB supported significant fat reduction and improved lean-to-fat ratio .
  • Insulin and metabolic health: goBHB lowered insulin and improved lipid biomarkers in controlled studies .
  • Muscle protection: By providing direct ATP, BHB helps maintain muscle metabolism during caloric deficit .

Together, this positions goBHB® as a science-based companion to GLP-1 therapy—addressing immediate tolerability and long-term weight maintenance.

Key Messages for Consumers

  • Optimize Your GLP-1 Experience: Minimize discomfort and maximize fat loss.
  • Protect Muscle, Lose Fat: Preserve strength while targeting body fat.
  • Keep the Weight Off: Support metabolism and appetite control post-treatment .

The Opportunity for Brands

As GLP-1 adoption grows, so does the need for adjunct nutrition strategies. goBHB® gives formulators a clinically backed ingredient that enhances therapy and extends results—positioning products for leadership in the next wave of weight management nutrition.